Publications (134) ANA VILLEGAS MARTÍNEZ publications

2024

  1. Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut

    Annals of Hematology, Vol. 103, Núm. 3, pp. 725-727

2023

  1. Mutations in the RACGAP1 gene cause autosomal recessive congenital dyserythropoietic anemia type III

    Haematologica

2020

  1. Diagnóstico diferencial de las eritrocitosis. Hemoglobinas con alta afinidad por el oxígeno

    Anales de la Real Academia Nacional de Medicina, Núm. 137, pp. 35-43

2017

  1. Hb Moncloa: A new variant of haemoglobin that interferes in the quantification of Hb A1c

    Clinical Biochemistry, Vol. 50, Núm. 9, pp. 521-524

  2. Phenotype of mutations in the promoter region of the β-globin gene

    Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 874-878

2016

  1. HB Puerta del Sol [HBA1:c.148A>C], HB Valdecilla [HBA2:c.3G>T], HB Gran Vía [HBA2:c.98T>G], HB Macarena [HBA2:c.358C>T] and HB El Retiro [HBA2:c.364-366dupGTG]: Description of five new hemoglobinopathies

    Clinical Chemistry and Laboratory Medicine, Vol. 54, Núm. 4, pp. 553-560

2015

  1. Asociación de la hemoglobina Groene Hart con la hemoglobina J-París-I: primer caso en España

    Medicina Clinica, Vol. 144, Núm. 5, pp. 212-215

  2. Hb Cervantes, Hb Marañón, Hb La Mancha and Hb Goya: Description of 4 new haemoglobinopathies

    Clinical Biochemistry, Vol. 48, Núm. 10-11, pp. 662-667

  3. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

    Annals of Hematology, Vol. 94, Núm. 4, pp. 565-573

2014

  1. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models

    Journal of Immunology, Vol. 193, Núm. 11, pp. 5567-5575

  2. Hb Cibeles [α2 CD25(B6) (Gly → Asp)]: a novel alpha chain variant causing alpha-thalassemia

    International Journal of Hematology, Vol. 100, Núm. 6, pp. 599-601

2013

  1. Association in cis of the mutations +20 (C>T) in the 5′ untranslated region and IVS-II-745 (C>G) on the β-globin gene

    Hemoglobin, Vol. 37, Núm. 2, pp. 112-118

  2. Erythrocytosis in a child due to Hb andrew-minneapolis [β144(HC1) Lys→Asn (AAG>AAT or AAC)] associated with a Spanish (δβ) ;0-thalassemia

    Hemoglobin, Vol. 37, Núm. 1, pp. 48-55

  3. Guidelines on haemovigilance of post-transfusional iron overload

    Blood Transfusion, Vol. 11, Núm. 1, pp. 128-139

  4. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification

    Annals of Hematology, Vol. 92, Núm. 1, pp. 19-24

2012

  1. Another Hb with inclusion bodies β-thalassemia, owing to Hb Durham-N.C. [β114(G16) Leu > Pro]. First case described in Hispanic populations

    Annals of Hematology

  2. Study of three families with Hb agrinio [α29(B10)Leu→Pro, CTG>CCG (α2)] in the spanish population: Three homozygous cases

    Hemoglobin, Vol. 36, Núm. 6, pp. 526-532

  3. Thrombosis and severe asthenia as priority manifestations in paroxysmal nocturnal haemoglobinuria

    Annals of Hematology

2011

  1. Caracterización molecular de dos nuevas mutaciones de α° talasemia en 2 familias españolas (mutación - ED y - GP)

    Medicina Clinica, Vol. 136, Núm. 15, pp. 674-677

  2. Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response

    Current Medical Research and Opinion, Vol. 27, Núm. 5, pp. 951-960